What is Celldex Therapeutics's change in other assets?

Celldex Therapeutics (CLDX) reported change in other assets of -$6.28M in Q1 2026.

How has Celldex Therapeutics's change in other assets changed year-over-year?

Celldex Therapeutics's change in other assets decreased by 239.3% year-over-year, from -$1.85M to -$6.28M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Celldex Therapeutics CLDX Change in Other Assets

Change in Other Assets at other companies

Eli LillyLLY

$1.65B+98.4%

PfizerPFE

-$322.25M+61.9%

AmgenAMGN

-$8M-104%

IncyteINCY

-$9.19M-115%

Arcutis Biotherapeutics, Inc.ARQT

$11.73M+257%

Nektar TherapeuticsNKTR

——

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's change in other assets?: Celldex Therapeutics (CLDX) reported change in other assets of -$6.28M in Q1 2026.
How has Celldex Therapeutics's change in other assets changed year-over-year?: Celldex Therapeutics's change in other assets decreased by 239.3% year-over-year, from -$1.85M to -$6.28M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.